Header Logo

Connection

ALI DENKTAS to Treatment Outcome

Back to Details
This is a "connection" page, showing publications ALI DENKTAS has written about Treatment Outcome.
ALI DENKTAS
Connection Strength
0.535
Treatment Outcome
  1. Revascularization Options for Left Main Disease: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 06; 25(6):267-273.
    View in: PubMed
    Score: 0.067
  2. Suspected coronary fat embolism after liposuction. Catheter Cardiovasc Interv. 2018 12 01; 92(7):E449-E452.
    View in: PubMed
    Score: 0.047
  3. Paravalvular Regurgitation After TAVR: Time Heals, or Not? J Invasive Cardiol. 2015 Oct; 27(10):E226-8.
    View in: PubMed
    Score: 0.040
  4. Drug-eluting stents for acute myocardial infarction. Expert Opin Pharmacother. 2009 Jan; 10(1):19-34.
    View in: PubMed
    Score: 0.025
  5. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. JACC Cardiovasc Interv. 2008 Oct; 1(5):504-10.
    View in: PubMed
    Score: 0.024
  6. Management of Acute Coronary Syndrome in Patients With Transcatheter Aortic Valve Replacement: A Review. Catheter Cardiovasc Interv. 2025 03; 105(4):959-969.
    View in: PubMed
    Score: 0.019
  7. 2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee. JACC Cardiovasc Interv. 2023 05 22; 16(10):1239-1291.
    View in: PubMed
    Score: 0.017
  8. 2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee. Circ Cardiovasc Interv. 2023 04; 16(4):e000088.
    View in: PubMed
    Score: 0.017
  9. Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States. Int J Cardiol. 2023 Jan 01; 370:143-148.
    View in: PubMed
    Score: 0.016
  10. Meta-Analysis Comparing Percutaneous Closure Versus Medical Therapy for Patent Foramen Ovale. Am J Cardiol. 2022 06 01; 172:174-177.
    View in: PubMed
    Score: 0.016
  11. Targeted Hypothermia vs Targeted Normothermia in Survivors of Cardiac Arrest: A Systematic Review and Meta-Analysis of Randomized Trials. Am J Med. 2022 05; 135(5):626-633.e4.
    View in: PubMed
    Score: 0.015
  12. Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
    View in: PubMed
    Score: 0.015
  13. Long-Term Outcomes of Veteran Patients After Transcatheter Aortic Valve Replacement. J Invasive Cardiol. 2021 09; 33(9):E730-E737.
    View in: PubMed
    Score: 0.015
  14. Left Ventricle Mass Regression After Surgical or Transcatheter Aortic Valve Replacement in Veterans. Ann Thorac Surg. 2022 07; 114(1):77-83.
    View in: PubMed
    Score: 0.015
  15. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention. Cardiovasc Revasc Med. 2020 12; 21(12):1560-1566.
    View in: PubMed
    Score: 0.014
  16. Temporal Trends and Outcomes of Percutaneous Coronary Atherectomy in the United States. J Invasive Cardiol. 2020 05; 32(5):E110-E121.
    View in: PubMed
    Score: 0.014
  17. Network Analysis of Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement for Stenotic Bicuspid Aortic Valves According to Valve Type. Cardiovasc Revasc Med. 2020 09; 21(9):1076-1085.
    View in: PubMed
    Score: 0.013
  18. Temporal trends, outcomes, and predictors of mortality after pericardiocentesis in the United States. Catheter Cardiovasc Interv. 2020 02 15; 95(3):375-386.
    View in: PubMed
    Score: 0.013
  19. Pasta without sauce? Catheter Cardiovasc Interv. 1999 Nov; 48(3):269-70.
    View in: PubMed
    Score: 0.013
  20. Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol. 2020 02 01; 300:106-112.
    View in: PubMed
    Score: 0.013
  21. Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
    View in: PubMed
    Score: 0.013
  22. Transcatheter aortic valve replacement for bicuspid aortic valve stenosis. Cleve Clin J Med. 2018 10; 85(10):786-788.
    View in: PubMed
    Score: 0.012
  23. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.012
  24. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 2016 Nov 15; 88(6):971-977.
    View in: PubMed
    Score: 0.011
  25. Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64.
    View in: PubMed
    Score: 0.009
  26. Comparison of outcomes for patients =75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2014 Jan 01; 113(1):60-3.
    View in: PubMed
    Score: 0.009
  27. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2013 Jun 01; 111(11):1576-9.
    View in: PubMed
    Score: 0.008
  28. The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination. JACC Cardiovasc Interv. 2011 Aug; 4(8):877-83.
    View in: PubMed
    Score: 0.007
  29. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol. 2006 Sep 15; 98(6):729-33.
    View in: PubMed
    Score: 0.005
  30. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv. 2004 Oct; 63(2):152-7.
    View in: PubMed
    Score: 0.005
  31. Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. Am Heart J. 2004 Sep; 148(3):501-6.
    View in: PubMed
    Score: 0.005
  32. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv. 2004 Apr; 61(4):484-91.
    View in: PubMed
    Score: 0.004
  33. Relation of Thrombolysis in Myocardial Infarction (TIMI) frame count to coronary flow parameters. Am J Cardiol. 2003 Feb 15; 91(4):466-9.
    View in: PubMed
    Score: 0.004
  34. Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience. J Invasive Cardiol. 2002 Dec; 14(12):720-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.